Holen Sie sich die Stockscreener-App
64.58
0.02%
0.1101
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BMY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Bristol Myers Squibb Co Aktie (BMY) Neueste Nachrichten
What macro factors could move Bristol Myers Squibb (NYSE:BMY) shares this week? - Kalkine Media
National Coalition of Pharmaceutical Industry, Academic, and Nonprofit Partners Launches Fifth Winn CIPP Cohort - Finviz
SOTYKTU Clinical, Regulatory and Commercial Intelligence Report 2026 - GlobeNewswire Inc.
Bristol Myers Squibb Company $BMY Shares Purchased by Waverly Advisors LLC - MarketBeat
CD&R Taps Former Bristol-Myers CEO Caforio in Healthcare Push - Bloomberg.com
Bristol-Myers Squibb stock heads into the open after a 3.2% drop - AD HOC NEWS
Bristol-Myers Squibb Co (BMY) Shares Fall 3.2% -- What GF Score of 71 Tells Investors - GuruFocus
Bristol Myers Squibb Co. stock underperforms Tuesday when compared to competitors - MarketWatch
Bristol-Myers Squibb Co Stock (BMY) Moved Down by 3.25% on Sep 8: Facts Behind the Movement - tradingkey.com
Bristol Myers' blood cancer cell therapy succeeds in mid-stage trial | Business Information & News | FE - Westlaw Today
What's Going On With Bristol Myers Stock Today?Bristol-Myers Squibb (NYSE:BMY) - Benzinga
Bristol Myers Squibb stock gains on positive arlocabtagene autoleucel trial results - AD HOC NEWS
Roivant surges on ‘exceptional’ results; Bristol Myers touts first-of-its-kind CAR-T therapy - Yahoo Finance
Bristol Myers' blood cancer cell therapy succeeds in mid-stage trial - Reuters
Why Is Bristol Myers Squibb (NYSE:BMY) Under NYSE Focus Today? - Kalkine Media
Bristol Myers Squibb Company $BMY Shares Acquired by Amundi - MarketBeat
Bristol Myers Squibb stock heads into the open after a 1.9% slide - AD HOC NEWS
Radioligand Therapy Market to Grow from USD 2.98 Billion in 2025 to USD 15.85 Billion by 2035, at a CAGR of 18.2% - GlobeNewswire Inc.
VIRGINIA RETIREMENT SYSTEMS ET Al Takes $99.23 Million Position in Bristol Myers Squibb Company $BMY - MarketBeat
TD Waterhouse Canada Inc. Buys 53,881 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Why Davy thinks Bristol-Myers Squibb’s latest rally is one to cash in on - Business Post
Saudi Central Bank Purchases 67,780 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb Company $BMY Shares Sold by Mid American Wealth Advisory Group Inc. - MarketBeat
Bristol-Myers Squibb (NYSE:BMY) Flashes Strong Technical Breakout Setup - ChartMill
Munich Reinsurance Co Stock Corp in Munich Raises Stock Position in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb Company $BMY Shares Purchased by NEOS Investment Management LLC - MarketBeat
Bristol Myers Squibb Company $BMY Position Boosted by Concurrent Investment Advisors LLC - MarketBeat
Atopic Dermatitis Drugs Market Set to Reach USD 33.42 Billion by 2035, at a CAGR of 7.70% - GlobeNewswire Inc.
Bristol Myers Squibb Co. stock underperforms Friday when compared to competitors - MarketWatch
Will Long‑Term Camzyos Data and Real‑World Evidence Change Bristol Myers Squibb's (BMY) Narrative? - simplywall.st
Will Camzyos' Long-Term Benefits Strengthen BMY's Growth Outlook? - TradingView
Bristol-Myers Squibb stock steadies as CAR-T trial pause meets strong Q2 2026 figures - AD HOC NEWS
A Wall Street Analyst Spotted the Trial Freeze—Then Came News of Three Deaths - Benzinga
Bristol Myers Squibb: Still Cheap, Despite What The Chart Says (NYSE:BMY) - Seeking Alpha
Bristol Myers Squibb: Buy The Growth Portfolio At A Value Price (NYSE:BMY) - Seeking Alpha
Bristol Myers Squibb Company $BMY Shares Bought by Burford Brothers Inc. - MarketBeat
Bristol Myers Squibb stock gains on Q2 beat and raised 2026 guidance - AD HOC NEWS
Bristol-Myers Squibb Stock: Is BMY Outperforming the Healthcare Sector? - Barchart.com
Revisiting Stock Picks Dexcom, Bristol Myers Squibb, Quanta Services - Barron's
Bristol Myers Squibb stock gains on CAR-T pause and Camzyos momentum - AD HOC NEWS
Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Autoimmune CAR-T faces tough questions after Novartis, Bristol Myers study halts - BioPharma Dive
Cellares downsizes New Jersey operations after losing BMS cell therapy contract - fiercepharma.com
Stripped of AstraZeneca safety net, BMS could face ‘carnage’ if high-risk clinical trial fails - BioSpace
Bristol-Myers Squibb stock holds the mid-$60 range - AD HOC NEWS
Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns - BioPharma Dive
Quantitative Investment Management LLC Makes New Investment in Bristol Myers Squibb Company $BMY - MarketBeat
Wellington Management Group LLP Has $225.53 Million Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
Benjamin Edwards Inc. Acquires 18,656 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Davidson Investment Advisors Sells 15,902 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Flputnam Investment Management Co. Purchases 26,360 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb (BMY) Unveils Five Year Camzyos Data At ESC Congress - simplywall.st
Opinion: Bristol Myers Squibb Is a Buy -- but the Real Reason Why Might Surprise Investors - The Motley Fool
Bristol Myers Squibb reports 97.4% of patients below heart blockage threshold - Stock Titan
Bristol Myers Squibb (BMY) Stock Looks Reasonable On Earnings Yet Strong Returns Test Value - Yahoo Finance
Archer Investment Corp Takes $1.40 Million Position in Bristol Myers Squibb Company $BMY - marketbeat.com
Bristol Myers Squibb (BMY) After ZENBEXUS Approval Faces A Fully Valued Debate - simplywall.st
Glenview Trust Co Invests $5.89 Million in Bristol Myers Squibb Company $BMY - MarketBeat
Jupiter Topco LLC Makes New Investment in Bristol Myers Squibb Company $BMY - marketbeat.com
Pure Financial Advisors LLC Invests $1.29 Million in Bristol Myers Squibb Company $BMY - MarketBeat
Cellares suffers financial blow as Bristol Myers Squibb ends collaboration - BioProcess International
33,855 Shares in Bristol Myers Squibb Company $BMY Bought by Pingora Partners LLC - MarketBeat
Bristol-Myers Squibb (BMY) SVP and Controller Phil Holzer Sells 500 Shares - GuruFocus
Primecap Management Co. CA Takes $1.44 Billion Position in Bristol Myers Squibb Company $BMY - MarketBeat
OMERS ADMINISTRATION Corp Purchases Shares of 173,350 Bristol Myers Squibb Company $BMY - MarketBeat
Cullen Capital Management LLC Invests $65.25 Million in Bristol Myers Squibb Company $BMY - MarketBeat
Meiji Yasuda Asset Management Co Ltd. Buys New Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
42,000 Shares in Bristol Myers Squibb Company $BMY Acquired by Barbara Oil Co. - MarketBeat
79,705 Shares in Bristol Myers Squibb Company $BMY Bought by Te Ahumairangi Investment Management Ltd - MarketBeat
Daiichi Life Insurance Co. Ltd. Takes Position in Bristol Myers Squibb Company $BMY - MarketBeat
Emerald Investment Advisers LLC Makes New $1.83 Million Investment in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol-Myers Squibb (BMY) Bets $2.3 Billion on Texas While Eli Lilly (LLY) Wins in the UK - Yahoo Finance
0.21%
0.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):